<DOC>
	<DOCNO>NCT02634905</DOCNO>
	<brief_summary>- Atopic dermatitis chronic relapsing disease , highly prevalent child ( 15 % ) . Therapeutic patient education ( TPE ) recognize key priority topic future AD research . The strong evidence favour TPE efficacy AD come large study assess repeat multi-disciplinary group education session hospital set . However , type intervention resource time consume adapt typical French practice . However , french dermatology center , simple `` first level '' nurse-led TPE intervention offer addition physician consultation . Unfortunately , content intervention seem vary greatly depend caregiver center benefit practice yet assess . Therefore , nurse-led TPE consider current care France AD patient . - Thus , need rigorously assess benefit additional , well-structured , simple nurse-led individual TPE intervention child AD family compare standard care alone . This study first large , adequately power , multicenter RCT trial assess type intervention child AD .</brief_summary>
	<brief_title>A Multicenter Randomized Control Trial Children With Moderate Severe Atopic Dermatitis Assess Benefit Nurse-led One-to-one Education Program Addition Standard Care Compared Standard Care Alone Long Term Control Disease Severity 6 Months</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Patient AD , define accord criterion United Kingdom Working Party : AD diagnose child itchy skin condition plus three following : Protocol EDU DA RC15_0035 Version nÂ°4 du 15/09/16 Page 28 sur 44 CONFIDENTIAL Visible flexural dermatitis involve skin crease , bend elbow behind knee ( visible dermatitis cheek and/or extensor area child age 10 year ) Personal history flexural dermatitis ( dermatitis cheek and/or extensor area child 10 year ) Personal history dry skin last 12 month Personal history asthma allergic rhinitis ( history atopic disease firstdegree relative child age 4 year ) Onset sign symptom age 2 year ( criterion use child age less 4 year ) . Patient age least 3 month le 18 year . SCORAD 20 ( moderate severe AD ) Patient receive treatment antiinflammatory topical treatment ( topical corticosteroid topical tacrolimus ) Informed consent parent Agreement child appropriate Patient affiliate French social security system Patient meet criterion AD SCORAD &lt; 20 Patient age 18 year Patient treat oral corticosteroid currently systemic immunosuppressant 2 month prior eligibility assessment Patients primary immunodeficiency disease . Consent give Patient affiliate French social security system Patient intercurrent disease , may exclude investigator believe participation trial best interest patient Personal decision child parent include Child / parent lack mental capacity give inform consent Child / Parents sufficient command French language understanding TPE program . Patient parent already receive structured TPE AD .</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>atopic dermatitis</keyword>
	<keyword>Therapeutic patient education</keyword>
	<keyword>pediatric dermatology</keyword>
</DOC>